NEW
YORK, Sept. 21, 2023 /PRNewswire/ -- PAVmed Inc.
(Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage
medical technology company operating in the medical device,
diagnostics, and digital health sectors, and its majority-owned
subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or "Lucid
Diagnostics"), a commercial-stage cancer prevention diagnostics
company, today announced their participation in the 2023 Cantor
Fitzgerald Global Healthcare Conference in New York City.
Lishan Aklog, M.D., PAVmed and
Lucid's Chairman & Chief Executive Officer, and Dennis McGrath, PAVmed's President and Chief
Financial Officer and Lucid's Chief Financial Officer, will
participate in a panel presentation on Wednesday, September
27, 2023, at 8:00 a.m. EDT.
About PAVmed and its Subsidiaries
PAVmed Inc. is a diversified commercial-stage medical technology
company operating in the medical device, diagnostics, and digital
health sectors. Its majority-owned subsidiary, Lucid
Diagnostics Inc. (NASDAQ: LUCD), is a commercial-stage cancer
prevention medical diagnostics company that markets the
EsoGuard® Esophageal DNA Test and
EsoCheck® Esophageal Cell Collection Device—the
first and only commercial tools for widespread early detection of
esophageal precancer to mitigate the risks of esophageal cancer
deaths. Its other majority-owned subsidiary, Veris Health
Inc., is a private, commercial-stage digital health company focused
on enhancing cancer care through remote monitoring and virtual
care using the Veris Cancer Care Platform. Veris is concurrently
developing a fully implantable, intelligent, physiologic monitor
for attachment and coimplantation with a vascular access port that
will further enhance the clinical and commercial value of the
platform by providing physiologic data to the care providers,
independent of patient compliance.
For more and for more information about PAVmed, please
visit pavmed.com.
For more information about Lucid Diagnostics, please
visit luciddx.com.
For more information about Veris Health, please
visit verishealth.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pavmed-and-lucid-diagnostics-to-participate-in-panel-presentation-at-the-2023-cantor-fitzgerald-global-healthcare-conference-301934820.html
SOURCE PAVmed Inc.